CCIA
AGN

Campbell & Co Investment Adviser’s Allergan Inc AGN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-47,300
Closed -$3.98M – 450
2013
Q2 		$3.98M Buy
+47,300
New +$4.91M 0.77% 35

Other funds holding AGN

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Campbell & Co Investment Adviser's AGN Position: Q3 2013 in Review

Campbell & Co Investment Adviser sold out of Allergan Inc (AGN) in Q3 2013, closing a stake of 47,300 shares — an estimated $3.98M sold.

Campbell & Co Investment Adviser first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $3.98M in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • Campbell & Co Investment Adviser reported no remaining Allergan Inc position as of Q3 2013 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 47,300 Allergan Inc shares in Q3 2013, an estimated $3.98M.
  • Campbell & Co Investment Adviser first reported a position in Allergan Inc in Q2 2013 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Allergan Inc position peaked at $3.98M in Q2 2013.
  • 642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2013, filed 6 Nov 2013.